Daniel D. Gretler

Clinical Significance of Thrombocytopenia During a Non–ST-Elevation Acute Coronary Syndrome

Matthew W. McClure, Scott D. Berkowitz, Rodney Sparapani et al. · Circulation · 1999 · 166 citations

Medicine, Cardiology, Hematology +17

A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT)

Kenneth Bauer, Bruce L. Davidson, Michael Gent et al. · Thrombosis and Haemostasis · 2008 · 159 citations

Medicine, Orthopaedic Surgery, Surgery +17

Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa)

Stuart J. Connolly, John W. Eikelboom, Paul Dorian et al. · European Heart Journal · 2013 · 127 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension.

W.J. Elliott, Roy R. Weber, K. S. Nelson et al. · Circulation · 1990 · 125 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Randomized COMparison of Platelet Inhibition With Abciximab, TiRofiban and Eptifibatide During Percutaneous Coronary Intervention in Acute Coronary Syndromes

Wayne Batchelor, Thaddeus R. Tolleson, Yao Huang et al. · Circulation · 2002 · 123 citations · Full text

Medicine, Cardiology, Pharmacology +17